Key takeaways:
Wegovy can be a helpful addition to a weight-loss treatment plan for some people. But it’s important to be aware of some of the possible side effects of this medication.
Some side effects can cause long-term complications. These include gallbladder and pancreas problems, stomach paralysis, and blocked intestines. But most of the time, these issues improve by stopping the medication.
Early studies suggested rare but serious health risks with Wegovy, like thyroid cancer and suicidal thoughts. But follow-up research hasn’t shown these risks.
Medications like Wegovy have helped a lot of people reach their weight-loss goals. But like all medications, there are potential risks.
Many people are familiar with some of the immediate side effects — like nausea or low blood sugar. But this medication has only been approved by the FDA since 2021, so healthcare professionals and people who use it are still learning about some of the longer-term complications of taking Wegovy and similar medications. Here we take a closer look at 10 long-term risks of Wegovy.
Wegovy can lead to problems with the gallbladder and bile duct system. The gallbladder is an organ near the liver. It stores bile, a yellowish liquid that helps digest fats. When you eat, the gallbladder releases bile through a duct system that connects to the intestine. This helps you break down and absorb fat from your diet.
Wegovy can increase the risk of gallstones and inflammation of the gallbladder. This could be related to the weight loss itself, because when people lose a lot of weight (or lose weight quickly), they are at higher risk of experiencing gallbladder issues. But it’s possible that the medication itself may also increase the risk.
Gallbladder issues like inflammation and gallstones can cause blockages in the bile duct system. The symptoms of gallbladder problems include:
Abdominal pain
Fever
Nausea
Vomiting
In the short term, these issues can be treated. But more severe cases may require surgery to remove gallstones and/or the gallbladder itself. And any surgery can increase your risk for longer-term health complications. So it’s important to be aware of this risk.
But these side effects are rare. Less than 2% of adults taking Wegovy developed gallstone problems.
Pancreatitis, or inflammation of the pancreas, is another serious but rare side effect of Wegovy seen in clinical trials.
The pancreas is another digestive organ near the gallbladder. It releases enzymes and hormones that help regulate metabolism and digestion. If the pancreas becomes inflamed, it can cause intense abdominal pain and frequent vomiting.
Like the gallbladder problems, these issues can be treated. But they can also lead to long-term complications in more severe cases.
It should be noted that a recent review casts doubt on the link between Wegovy and pancreatitis. But others still confirm a small risk. It’s not clear if having a history of pancreatitis in the past increases the risk of being diagnosed with pancreatitis while taking Wegovy. And pancreatitis cannot always be prevented. But limiting alcohol or avoiding it altogether will lower your risk of the condition.
How does Wegovy stack up against Zepbound? They have similar active ingredients, but there are differences. Here’s what to know about Wegovy versus Zepbound for weight loss.
There are several options for GLP-1s: Our experts break down GLP-1 options so you can make an informed decision about which is best for you.
Are Ozempic and Wegovy knockoffs safe? Many people turn to compounding pharmacies when they can’t otherwise get semaglutide. It’s important to know how they work and the risks involved.
One of the ways that Wegovy helps with weight loss is by slowing down stomach emptying. This makes people feel full with smaller amounts of food. But some people taking Wegovy and similar medications have developed stomach paralysis (also known as gastroparesis.)
With gastroparesis, food and liquids in the stomach don’t empty into the intestines as they should. The stomach contents may remain in the stomach for a prolonged period of time. This can lead to:
Nausea
Vomiting
Abdominal pain
Bloating
Uncomfortable feelings of fullness
Gastroparesis wasn’t noted in the initial clinical trials of Wegovy. But as more people are taking Wegovy, a few people have experienced this condition. And some studies have found a potential link. In some cases, gastroparesis went away when the medication was stopped, but not always.
Certain situations and health conditions can increase a person’s risk for gastroparesis — so be careful taking Wegovy if you have any of the following:
Medications that slow down your digestive system, like opioids
Prior stomach surgery
Certain nervous system conditions like multiple sclerosis or Parkinson’s disease
Recent research has revealed that Wegovy may lead to another serious digestive complication. Some people reported blocked intestines, also called a bowel obstruction, while taking Wegovy. This is when food gets stuck in the intestine and creates a blockage, preventing intestinal contents from moving in the right direction.
Bowel obstruction can cause intense abdominal pain, nausea, and vomiting. Similar to the side effects above, this complication is rare. But it’s a serious condition that requires emergency care and even surgery.
Some people have experienced acute kidney injury while taking Wegovy. Here’s why.
Wegovy’s common side effects of nausea, vomiting, and diarrhea can all lead to dehydration. And, more severe cases of dehydration can affect the kidneys. With severe dehydration, the kidneys don’t receive enough blood flow, causing kidneys to not function as well as the body needs them to. But this kind of kidney injury is usually reversible — that is, it gets better once someone is rehydrated.
If you have underlying kidney problems, or if you experience severe gastrointestinal side effects that could make you dehydrated, your medical care team may recommend monitoring your kidney function while you take Wegovy.
Hair loss was reported by 3% of people taking Wegovy, compared to 1% of people taking a placebo in clinical trials. But it seems to be more rare in follow-up studies. It’s more likely that hair loss is due to weight loss rather than the medication itself. After all, rapid weight loss — like after weight-loss surgery — is known to cause hair loss. And, this can happen with the weight loss caused by Wegovy, too.
The condition leading to hair loss caused by Wegovy is known as telogen effluvium, or stress-related hair loss. If you do experience hair loss, the effect is usually temporary. But there are steps you can take to help prevent hair loss or help it regrow while taking Wegovy, including:
Making sure you get enough protein and nutrition from your diet
Relieving stress with meditation or mindfulness practice
Getting plenty of exercise
People taking Wegovy in clinical trials experienced small increases in their heart rates. Their heart rates increased by 1 to 4 beats per minute, on average. But some people had even greater increases.
For many people, this may not be a problem (or noticeable). But increased heart rate can be a bigger deal for people with heart conditions, like atrial fibrillation or heart failure.
If you feel missed heartbeats, palpitations, or racing heartbeat at rest while taking Wegovy, it’s a good idea to discuss this with your healthcare team. If your heart rate is consistently increased on Wegovy, you may need to discontinue the medication.
In people who have diabetes, taking Wegovy may increase the risk of developing diabetic retinopathy. This condition affects the blood vessels in the back of the eye and can lead to vision loss.
The active ingredient in Wegovy, semaglutide, is also used to treat high blood sugar in people with diabetes. It sounds contrary, but rapid improvement in blood sugar can worsen diabetic retinopathy in the short term. If you have diabetes or diabetic retinopathy and plan to start Wegovy, it’s important to discuss this risk with a healthcare professional.
Semaglutide has also been linked to another rare eye condition that affects vision, but experts are still working out the exact details.
Wegovy carries an FDA black box warning regarding its possible association with a rare type of thyroid tumor. This was discovered during safety studies in rodents that were given semaglutide, the active ingredient in Wegovy. But it’s difficult to make a direct comparison between the effects of semaglutide on rodents and the effect of Wegovy in humans.
Follow-up studies in humans suggest an incidence of less than 1%, so the risk seems to be very low. But the makers of Wegovy still say that certain groups of people at high risk of thyroid tumors should avoid taking Wegovy. These include people with:
Personal or family history of medullary cell carcinoma of the thyroid
Multiple endocrine neoplasia syndrome type 2 (MEN2)
Some people who took Wegovy in clinical trials reported suicidal thoughts. This side effect wasn’t common, but it’s a serious side effect. The FDA has been investigating whether there’s an increased risk of suicidal thoughts when taking Wegovy.
Preliminary data and follow-up data haven’t shown a link between medications like Wegovy and suicidal thoughts, but the research is ongoing. It’s important to be aware of this potential side effect, especially if you have a history of mental health conditions such as depression.
Depression is a common mental health condition that affects how someone thinks and feels. And having depression doesn’t necessarily cause someone to have suicidal thoughts. But some people may experience worsening depression or severe depression with thoughts of suicide.
If you have a history of severe depression or have had suicidal thoughts in the past, it’s especially important to discuss this with a medical professional before starting Wegovy. Let them know right away if you have any new or worsening depression symptoms or suicidal thoughts while taking the medication.
If you’re taking Wegovy, and you’ve noticed these or other side effects, it’s best to get help. Consider speaking with the healthcare professional who prescribed it for you as soon as you can. They can help rule out other causes of your symptoms and help you come up with a plan for next steps.
Regaining some weight is common after stopping the medication. One clinical trial showed that after 1 year, people had gained about two-thirds of the amount of weight they had lost with the medication. If you do plan to stop taking it, experts suggest tapering the dose before stopping, if possible.
Wegovy and Ozempic are brand names of the same medication: semaglutide. The FDA has approved Wegovy for weight loss and Ozempic for diabetes. They have different dosages but cause similar side effects.
There’s not much data looking specifically at Wegovy use in people without a gallbladder. So, as with other prescription medications, it’s best to discuss your situation with a healthcare professional before taking it.
Wegovy has powerful benefits for weight-loss treatment. But like any medication, it also has potential side effects. Wegovy most commonly causes gastrointestinal problems, and some of these can be serious. Fortunately, the serious side effects seem to be rare.
But because Wegovy and similar medications are still fairly new, there’s a lot experts don’t know about potential long-term effects. The good news is this will change over time. But for now, it’s a good idea to discuss any concerning side effects of Wegovy with a healthcare professional before starting the medication.
If you or someone you know is experiencing thoughts of suicide or a mental health crisis, help is available. Call or text the 988 Suicide & Crisis Lifeline by dialing 988. This number connects you with free and confidential professional assistance.
European Medicines Agency. (2023). EMA statement on ongoing review of GLP-1 receptor agonists.
Feier, C. V. I., et al. (2024). Assessment of thyroid carcinogenic risk and safety profile of GLP1-RA semaglutide (Ozempic) therapy for diabetes mellitus and obesity: A systematic literature review. International Journal of Molecular Sciences.
Jairath, R., et al. (2024). 53028 Semaglutide and hair loss: A real-world analysis. Journal of the American Academy of Dermatology.
Masson, W., et al. (2024). Acute pancreatitis due to different semaglutide regimens: An updated meta-analysis. Endocrinología, Diabetes y Nutrición.
Novo Nordisk Inc. (2024). Wegovy -semaglutide injection [package insert].
Prillaman, M., et al. (2024). What happens when you quit Ozempic and Wegovy? Scientific American.
Sodhi, M., et al. (2023). Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss. JAMA.
Sullivan, K. (2023). Some people taking weight loss drugs say they're experiencing hair loss. NBC News.
U.S. Food and Drug Administration. (2024). Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity.
Wang, W., et al. (2024). Association of semaglutide with risk of suicidal ideation in a real-world cohort. Nature Medicine.
Wilding, J. P. H., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism.
Zhang, W., et al. (2021). Hair loss after metabolic and bariatric surgery: A systematic review and meta-analysis. Obesity Surgery.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.